Osocimab

CAS No. 2056878-75-0

Osocimab( —— )

Catalog No. M36825 CAS No. 2056878-75-0

Osocimab (BAY 1213790) is a potent anti-FXIa antibody with a Ki value of 2.4 nM and an EC50 value of 0.2 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 493 In Stock
10MG 793 In Stock
25MG 1169 In Stock
50MG 1553 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Osocimab
  • Note
    Research use only, not for human use.
  • Brief Description
    Osocimab (BAY 1213790) is a potent anti-FXIa antibody with a Ki value of 2.4 nM and an EC50 value of 0.2 nM.
  • Description
    Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    FXR
  • Recptor
    FXR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2056878-75-0
  • Formula Weight
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Schaefer M, et al. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI. J Mol Biol. 2019 Dec 6;431(24):4817-4833. ?
molnova catalog
related products
  • Tropifexor

    Tropifexor (LJN-452, LJN452)?is a novel highly potent, selective, orally acitive FXR full agonist with EC50 of 0.26 nM.

  • Nidufexor

    Nidufexor (LMB763, LMB-763) is a novel potent farnesoid X receptor (FXR) agonist?for the treatment of non-alcoholic steatohepatitis (NASH) and hepatobiliary disorders.

  • WAY-362450

    A highly potent, selective, and orally active agonist of FXR with EC50 of 4 nM.